Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 70858 CHARLOTTE, NC
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$75,098,873
-$8,686,670 QoQ
Shares Held
1,193,182
-0.1% QoQ
Ownership
2.72%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#11
of 256 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 77% Shared 0% None 23%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. TARS ranks #32 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in TARS

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $75,098,873 1,193,182
2026-03-31 $83,785,543 1,194,377
2025-12-31 $62,073,717 758,106
2025-09-30 $31,855,844 536,023
2025-06-30 $18,889,000 466,280
2025-03-31 $22,045,125 429,144
2024-12-31 $18,707,086 337,856
2024-09-30 $7,678,760 233,468
2024-06-30 $6,607,782 243,112
2024-03-31 $8,342,032 229,492
2023-12-31 $4,836,165 238,823
2023-09-30 $2,546,298 143,292
2023-06-30 $2,249,820 124,506
2023-03-31 $288,592 22,959
2022-12-31 $227,873 15,544
2022-09-30 $198,932 11,620
2022-06-30 $364,211 24,946
2022-03-31 $109,312 6,499
2021-12-31 $239,895 10,662
2021-09-30 $124,363 5,771
2021-06-30 $56,800 1,960
2021-03-31 $297,707 9,237
2020-12-31 $61,291 1,483